Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Pharmaceuticals: Fampridine Newbury Approved By Swedish Health Authorities

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    27/12/2022 09:04
    Dec 27 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * FAMPRIDINE NEWBURY APPROVED BY SWEDISH HEALTH AUTHORITIES
    * MARKETING AUTHORIZATION (MA) OF FAMPRIDINE NEWBURY 10 MG
PROLONGED-RELEASE TABLETS IN SWEDEN AS FIRST COUNTRY IN A
SCANDINAVIAN REGISTRATION PROCEDURE
    * APPROVALS IN NORWAY, DENMARK EXPECTED TO FOLLOW UPON
FINALIZED
NATIONAL REVIEWS

Source text for Eikon:  ID:nMFN4CzvWG 
Further company coverage:  NEWBRY.ST 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Newbury Pharmaceuticals AB

    See all news